Overview

A Study to Investigate How AZD4144 Affects the Pharmacokinetics of Rosuvastatin in Healthy Participants

Status:
COMPLETED
Trial end date:
2025-06-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics (PK) of rosuvastatin when administered alone and in combination with single oral dose of AZD4144.
Phase:
PHASE1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Rosuvastatin Calcium